Royal Bank of Canada
RLAY icon

Royal Bank of Canada’s Relay Therapeutics RLAY Stock Holding History

Royal Bank of Canada’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Sell
146
-3,914
-96% -$35K ﹤0.01% 6939
2025
Q4 		$35K Sell
4,060
-216,493
-98% -$1.54M ﹤0.01% 5742
2025
Q3 		$1.15M Sell
220,553
-217,479
-50% -$829K ﹤0.01% 3876
2025
Q2 		$1.52M Buy
438,032
+425,957
+3,528% +$1.27M ﹤0.01% 3538
2025
Q1 		$31K Sell
12,075
-3,253
-21% -$12.7K ﹤0.01% 5763
2024
Q4 		$63K Buy
15,328
+5,184
+51% +$28.2K ﹤0.01% 5577
2024
Q3 		$72K Buy
10,144
+758
+8% +$5.66K ﹤0.01% 5528
2024
Q2 		$61K Buy
9,386
+7,264
+342% +$49.6K ﹤0.01% 5555
2024
Q1 		$18K Sell
2,122
-25,675
-92% -$250K ﹤0.01% 5970
2023
Q4 		$306K Buy
27,797
+12,639
+83% +$107K ﹤0.01% 4715
2023
Q3 		$127K Buy
15,158
+5,738
+61% +$61.7K ﹤0.01% 5198
2023
Q2 		$118K Buy
9,420
+4,602
+96% +$57.2K ﹤0.01% 5196
2023
Q1 		$79K Sell
4,818
-9,632
-67% -$173K ﹤0.01% 5351
2022
Q4 		$216K Buy
14,450
+13,163
+1,023% +$252K ﹤0.01% 4812
2022
Q3 		$29K Buy
1,287
+856
+199% +$18.8K ﹤0.01% 5997
2022
Q2 		$7K Sell
431
-3,868
-90% -$82.9K ﹤0.01% 6527
2022
Q1 		$129K Sell
4,299
-26,429
-86% -$641K ﹤0.01% 5462
2021
Q4 		$944K Buy
30,728
+11,578
+60% +$366K ﹤0.01% 3878
2021
Q3 		$605K Buy
19,150
+14,997
+361% +$505K ﹤0.01% 4193
2021
Q2 		$152K Buy
4,153
+388
+10% +$12.8K ﹤0.01% 5297
2021
Q1 		$130K Buy
3,765
+3,422
+998% +$149K ﹤0.01% 5273
2020
Q4 		$14K Buy
343
+314
+1,083% +$14.2K ﹤0.01% 6232
2020
Q3 		$1K Buy
+29
New +$1.11K ﹤0.01% 6470

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Royal Bank of Canada's RLAY Position: Q1 2026 in Review

Royal Bank of Canada reduced its Relay Therapeutics (RLAY) stake by 96% in Q1 2026, selling an estimated $35K and leaving 146 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6939.

Royal Bank of Canada first reported a position in RLAY in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.52M in Q2 2025. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Royal Bank of Canada held 146 shares of Relay Therapeutics worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 3,914 Relay Therapeutics shares in Q1 2026, an estimated $35K.
  • Relay Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6939 holding.
  • Royal Bank of Canada first reported a position in Relay Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Royal Bank of Canada's Relay Therapeutics position peaked at $1.52M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.